Navigation Links
Cancer research presented at 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium
Date:12/1/2010

SAN ANTONIO More than 9,000 people from more than 90 countries will gather Dec. 8-12, 2010, at the Henry B. Gonzales Convention Center in San Antonio, Texas, for the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium.

The symposium is the largest of its kind anywhere in the world. Each year it draws academicians, clinicians, survivors, patient advocates, industry and others interested in the advancement of breast cancer research to discuss and learn about new and late-breaking research, which includes experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and pre-malignant breast disease, as well as new findings from clinical trials.

The CTRC-AACR San Antonio Breast Cancer Symposium is a partnership between the Cancer Therapy and Research Center (CTRC) at UT Health Science Center San Antonio, the American Association for Cancer Research and Baylor College of Medicine.

"The driving force behind this collaboration is the shared mission of the organizations to advance progress against breast cancer," said Program Chairperson C. Kent Osborne, M.D., director of the Dan L. Duncan Cancer Center at the Baylor College of Medicine. "By combining their respective strengths, the San Antonio Breast Cancer Symposium encompasses the full spectrum of breast cancer research and facilitates the rapid transition of new knowledge into improved care for breast cancer patients."

The symposium begins on Wednesday, Dec. 8, with a full schedule of educational events. The opening plenary session begins the next day at 8:30 a.m. CT in Exhibit Hall D of the Henry B. Gonzales Convention Center.

In addition to the ongoing plenary session, there is a full industry exhibit hall and a program for survivors and breast cancer advocates. Press conferences will be held for registered members of the media.


'/>"/>

Contact: Jeremy Moore
jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Page: 1

Related medicine news :

1. FDA Panel to Vote on Drugs Said to Prevent Prostate Cancer
2. Finger length points to prostate cancer risk
3. FDA Panel to Vote on Drugs to Prevent Prostate Cancer
4. Cancer risk from medical radiation may have been overestimated
5. Annual breast cancer screening beginning at age 40 reduces mastectomy risk
6. Active surveillance for low-risk prostate cancer may offer better quality-of-life
7. Breast Cancer Rates Lower With Less Hormone Therapy: Study
8. Study Backs Active Surveillance for Low-Risk Prostate Cancer
9. Celebrex may help prevent some non-melanoma skin cancers
10. Experimental vaccine sets sights on lung cancer
11. Drop in breast cancer rates directly tied to reduced hormone therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... NutraPre today announced the ... pregnant women to prevent morning sickness and promote overall heath. Engineered with advanced ... and taste of water. , “Imagine a pregnancy without morning sickness,” NutraPre CEO ...
(Date:5/23/2016)... Angeles, CA (PRWEB) , ... May 23, 2016 , ... ... surgeons have noted that, less than 1% of United Kingdom residents who could benefit ... UK’s National Health Service (NHS) increases the number of bariatric procedures it offers to ...
(Date:5/23/2016)... ... , ... NYDNRehab, a New York City-based physical therapy clinic , is ... this type of technology, which was developed by world-renowned researcher Dr. Christopher Powers of ... , With over 10 million sport injuries per year in the United ...
(Date:5/23/2016)... ... May 23, 2016 , ... The Society for Women’s Health ... to move on from that role. , “No one in Washington led the way ... said SWHR Founder Florence Haseltine, MD, PhD. “We offer our deep gratitude to Phyllis ...
(Date:5/23/2016)... , ... May 23, 2016 , ... ... care to residents of Westchester County for over 24 years, recently hosted its ... community members joined HOW for two remembrance ceremonies, each concluding with the release ...
Breaking Medicine News(10 mins):
(Date:5/20/2016)... 2016 - Revenue Forecasts ... Growth Hormones, Recombinant Coagulation Factors and Regenerative Medicine ... New Study Reveals Selling Opportunities and Revenue Prospects ... ,What is the future of biologics, especially new ... commercial analysis. Staying ahead in data and knowledge, ...
(Date:5/19/2016)... Calif. , May 19, 2016  According ... thirds of the world lacks basic diagnostic imaging. ... in the United States , ... to such technology. In fact, the WHO reports ... risk of avoidable or treatable death, simply due ...
(Date:5/19/2016)... According to a new market research report "Sunitinib Malate ... Germany , France , U.K., ... Japan )", published by MarketsandMarkets, The market is projected to ... from 2016 to 2021.      (Logo: http://photos.prnewswire.com/prnh/20160303/792302 ... through 26 Pages and in-depth TOC on "Sunitinib Malate ...
Breaking Medicine Technology: